Search for: "In Re Mdl" Results 281 - 300 of 1,536
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Nov 2016, 11:55 am by Michael Grossman
Louis court should not have presiding jurisdiction, the cases will have to be re-filed in another court. [read post]
8 Nov 2016, 9:00 pm by Doug Austin
Case Background In this multi-district litigation (MDL) against...Read the whole entry... [read post]
17 Oct 2016, 1:30 pm by Tom Lamb
By April 2016 there was a sufficient federal court Viagra lawsuits filed that the Judicial Panel on Multidistrict Litigation (JPML) decided to create the so-called Viagra MDL, known fully as IN RE: VIAGRA (SILDENAFIL CITRATE) PRODUCTS LIABILITY LITIGATION -- MDL No. 2691. [read post]
16 Oct 2016, 11:19 pm by Jarod Bona
That is exactly what plaintiffs alleged in Twombly and is what plaintiffs also alleged in the In re Insurance Brokerage Antitrust Litigation multi-district litigation (MDL). [read post]
16 Oct 2016, 11:19 pm by Jarod Bona
That is exactly what plaintiffs alleged in Twombly and is what plaintiffs also alleged in the In re Insurance Brokerage Antitrust Litigation multi-district litigation (MDL). [read post]
16 Oct 2016, 11:19 pm by Jarod Bona
That is exactly what plaintiffs alleged in Twombly and is what plaintiffs also alleged in the In re Insurance Brokerage Antitrust Litigation multi-district litigation (MDL). [read post]
14 Oct 2016, 7:56 pm by Schachtman
In yet another law review article on Daubert, Susan Haack has managed mostly to repeat her past mistakes, while adding a few new ones to her exegesis of the law of expert witnesses. [read post]
14 Oct 2016, 5:03 am by Kelly Hyman
  To support it’s argument, Cook also cited to In re Incretin Mimetics Prods. [read post]
28 Sep 2016, 12:10 pm by Clay Hodges
In Re: Xarelto (Rivaroxaban) Products Liability Litigation, MDL 2592 [read post]
28 Sep 2016, 12:10 pm by Clay Hodges
In Re: Xarelto (Rivaroxaban) Products Liability Litigation, MDL 2592 [read post]
16 Sep 2016, 8:30 am by Michael Grossman
By examining a present day controversy, such as the multi-district litigation (MDL) over the potential dangers of the drug Xarelto (rivaroxaban), we can gain a better insight into how this area of the law works and why we hold manufacturers accountable for dangerous and defective products. [read post]
30 Aug 2016, 9:45 pm by Andrew Trask
 And, based on the reactions of one set of litigants to a judge’s declaration that a settlement was “unfair” (instead of seeking mandamus, they re-negotiated to address the judge’s concerns), they believe MDL judges may simply need to be more aggressive in sharing their thoughts about the progress of the litigation. [read post]
30 Aug 2016, 9:33 am by Venkat Balasubramani
Numerous plaintiffs’ suits were heard as an MDL in the Northern District of California, and 23andMe moved to compel arbitration. [read post]
29 Aug 2016, 1:19 pm by Michael Grossman
While patients have several complaints about the drug, the current multi-district litigation (MDL) directed at Johnson & Johnson focuses mainly on one very uncomfortable side effect of Risperdal and/or Invega use. [read post]